Urology · Houston, TX
NPI
1114360450
Since 2013
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6560 Fannin St Ste 1440
Houston, TX, 77030
Phone (713) 790-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$302K
17,293 services
Medicare patients, 2024
687
Average age 77
Drug cost, 2024
$896K
4,316 prescriptions
Company payments, 2025
$6,785
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lara S Matheson was code J0585 (injection, onabotulinumtoxina, 1 unit), 3,900 times for 30 patients. In total Lara S Matheson billed 17,293 services in 94 codes, and Medicare paid $302K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 3,900 | 30 | $4.98 | $19K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,100 | 21 | $0.10 | $206 |
| 81003 Clinical Chemistry | Office | 1,072 | 612 | $2.20 | $2,356 |
| 99214 Office E&M - Established | Office | 965 | 551 | $91.61 | $88K |
| 51798 Ultrasound - Nonspecific | Office | 722 | 506 | $8.09 | $5,840 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 558 | 75 | $48.12 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 405 | 332 | $12.51 | $5,068 |
| 36415 Venipuncture Blood Collection | Office | 214 | 128 | $8.36 | $1,789 |
| 99204 Office E&M - New | Office | 208 | 208 | $120.62 | $25K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 136 | 53 | $38.13 | $5,186 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 97 | 95 | $52.35 | $5,078 |
| 52000 Cystourethroscopy | Office | 87 | 82 | $180.14 | $16K |
| 52000 Cystourethroscopy | Facility | 62 | 58 | $61.05 | $3,785 |
| 99443 Telephone Services | Office | 61 | 56 | $94.14 | $5,743 |
| 51701 Other Organ Systems | Office | 45 | 39 | $33.31 | $1,499 |
By year: 2022 $249K for 11,085 services; 2023 $302K for 15,317 services; 2024 $302K for 17,293 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,072 | 612 | $2.20 | $2,356 |
| 36415 Venipuncture Blood Collection | 214 | 128 | $8.36 | $1,789 |
Medicare prescription drug claims, 2024
In 2024, the drug Lara S Matheson prescribed most often to Medicare patients was Gemtesa (Vibegron), with 747 prescriptions and refills. In total Lara S Matheson wrote 4,316 Medicare prescriptions that cost $896K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 747 | 1,030 | 188 | $483K |
| Estradiol Generic | 553 | 1,305 | 309 | $40K |
| Tamsulosin Hcl Generic | 446 | 995 | 155 | $5,646 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 313 | 319 | 214 | $4,307 |
| Finasteride Generic | 255 | 583 | 65 | $3,318 |
| Cephalexin Generic | 238 | 298 | 53 | $2,674 |
| Myrbetriq Mirabegron | 219 | 326 | 70 | $146K |
| Ciprofloxacin Hcl Generic | 159 | 159 | 112 | $823 |
| Methenamine Hippurate Generic | 149 | 180 | 31 | $7,837 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 116 | 157 | 29 | $3,269 |
| Fosfomycin Tromethamine Generic | 115 | 117 | 42 | $26K |
| Cefpodoxime Proxetil Generic | 114 | 114 | 81 | $4,680 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 92 | 92 | 64 | $638 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 75 | 75 | 62 | $352 |
| Trospium Chloride Er Trospium Chloride | 64 | 122 | 20 | $14K |
Brand drugs: - claims; generic drugs: 3,115 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lara S Matheson $6,785 ($6,785 in general payments such as food, travel and fees) from 19 companies. The largest payer was HMU Consumables, LLC with $5,143.
| Company | Payments | Amount |
|---|---|---|
| HMU Consumables, LLC | 2 | $5,143 |
| Medtronic, Inc. MDT | 11 | $472 |
| Sumitomo Pharma America, Inc. 4506.T | 36 | $299 |
| Pfizer Inc. PFE | 6 | $176 |
| Abbvie Inc. ABBV | 4 | $109 |
| Dendreon Pharmaceuticals LLC | 2 | $68.37 |
| Endo USA, Inc. | 3 | $64.67 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $64.19 |
| Boston Scientific Corporation BSX | 1 | $59.99 |
| Antares Pharma, Inc. | 3 | $59.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.